Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 4
1981 3
1982 2
1983 1
1984 2
1985 1
1987 1
1988 1
1990 2
1991 4
1992 1
1993 3
1994 1
1995 5
1996 4
1997 3
1998 7
1999 3
2000 2
2001 8
2002 10
2003 10
2004 10
2005 16
2006 9
2007 18
2008 24
2009 33
2010 28
2011 34
2012 51
2013 59
2014 63
2015 78
2016 74
2017 73
2018 88
2019 105
2020 132
2021 154
2022 130
2023 105
2024 116
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,279 results

Results by year

Filters applied: . Clear all
Page 1
Antianginal effects of empagliflozin in patients with type 2 diabetes and refractory angina; a randomized, double-blind placebo-controlled trial (EMPT-ANGINA Trial).
Mansouri MH, Mansouri P, Sadeghi M, Hashemi SM, Khosravi A, Behjati M, Shahabi J, Mansouri A, Zavar R, Amirpour A, Sanei H, Sarrafzadegan N. Mansouri MH, et al. Clin Cardiol. 2024 Jan;47(1):e24158. doi: 10.1002/clc.24158. Epub 2023 Sep 18. Clin Cardiol. 2024. PMID: 37721420 Free PMC article. Clinical Trial.
RESULTS: The mean age of individuals in the empagliflozin and placebo groups was 67.46 9.4 and 65.47 7.0 years, respectively (p = .304). Patients who received empagliflozin showed a significant improvement in both the primary endpoint, which was the SAQ Summary Score (192. …
RESULTS: The mean age of individuals in the empagliflozin and placebo groups was 67.46 9.4 and 65.47 7.0 years, respectively (p = .30 …
The Beginning of the End.
Khoshpouri P, Bahar R, Khoshpouri P, Ebrahimi A, Ghahramani O, Singh Sekhon A, Mansouri S, Choo-Foo J, Khosa F. Khoshpouri P, et al. Am J Clin Pathol. 2021 May 18;155(6):873-878. doi: 10.1093/ajcp/aqaa190. Am J Clin Pathol. 2021. PMID: 33313715

Male faculty held higher academic ranks (being professor) and leadership positions (chair/program director) (P < .0001). Males were more likely to hold combined MD-PhD degrees (P < .0001) than females. The median h-index for the male faculty was 17 vs 9 for th

…

Male faculty held higher academic ranks (being professor) and leadership positions (chair/program director) (P < .0001). Males wer

…
The use of proteomics for the identification of promising vaccine and diagnostic biomarkers in Plasmodium falciparum.
Mansouri R, Ali-Hassanzadeh M, Shafiei R, Savardashtaki A, Karimazar M, Anvari E, Nguewa P, Rashidi S. Mansouri R, et al. Parasitology. 2020 Oct;147(12):1255-1262. doi: 10.1017/S003118202000102X. Epub 2020 Jun 19. Parasitology. 2020. PMID: 32618524 Free PMC article. Review.
There is growing evidence of drug-resistance in P. falciparum treatment, and the design of effective vaccines remains an ongoing strategy to control the disease. ...Therefore, the identification of novel antigenic proteins especially by proteomic tools is urgent for vaccin …
There is growing evidence of drug-resistance in P. falciparum treatment, and the design of effective vaccines remains an ongoing stra …
Periodontal phenotype modification in orthodontic patients.
Kadkhodazadeh M, Amid R, Moscowchi A, Mansouri H. Kadkhodazadeh M, et al. J Esthet Restor Dent. 2024 Apr;36(4):548-554. doi: 10.1111/jerd.13149. Epub 2023 Oct 18. J Esthet Restor Dent. 2024. PMID: 37850403

The results showed a statistically significant increase in GT (2.02 0.39 mm), KTW (1.11 0.82 mm), and VD (0.18 1.16 mm) (p < 0.05). GR was also significantly decreased (1.02 0.99 mm) (p < 0.05). CONCLUSION: Within the limitation of this study, the proposed app

…

The results showed a statistically significant increase in GT (2.02 0.39 mm), KTW (1.11 0.82 mm), and VD (0.18 1.16 mm) (p < 0.05)

…
First Report of Penicillium subrubescens Causing Root Rot of Knoxia roxburghii in China.
Liu C, Zhang L, Li H, Dong JH, He X, Qiu B. Liu C, et al. Plant Dis. 2023 Jul 27. doi: 10.1094/PDIS-05-23-0918-PDN. Online ahead of print. Plant Dis. 2023. PMID: 37498635 Free article.
Blast searches showed that the sequences of ITS (OQ954757) and TUB (OQ970059) of isolate ByF10 were 99% (MH865456) and 100% (KC797611) identical with P. subrubescens CBS 130205 and CBS 129617, respectively. A concatenated phylogenetic tree (ITS+TUB) constructed using the m …
Blast searches showed that the sequences of ITS (OQ954757) and TUB (OQ970059) of isolate ByF10 were 99% (MH865456) and 100% (KC797611) ident …
Competitive binding studies of the nucleosomal histone targeting drug, [Ru(eta(6)-p-cymene)Cl(2)(pta)] (RAPTA-C), with oligonucleotide-peptide mixtures.
Mansouri F, Ortiz D, Dyson PJ. Mansouri F, et al. J Inorg Biochem. 2023 Jan;238:112043. doi: 10.1016/j.jinorgbio.2022.112043. Epub 2022 Nov 1. J Inorg Biochem. 2023. PMID: 36370502 Free article.
Protein crystallography and biochemical assays reveal that the organometallic drug, [Ru(eta(6)-p-cymene)Cl(2)(pta)] (RAPTA-C), preferentially binds to nucleosomal histone proteins in chromatin. ...
Protein crystallography and biochemical assays reveal that the organometallic drug, [Ru(eta(6)-p-cymene)Cl(2)(pta)] (RAPTA-C), prefer …
P-Coumaric Acid Mitigates Doxorubicin-Induced Nephrotoxicity Through Suppression of Oxidative Stress, Inflammation and Apoptosis.
Rafiee Z, Moaiedi MZ, Gorji AV, Mansouri E. Rafiee Z, et al. Arch Med Res. 2020 Jan;51(1):32-40. doi: 10.1016/j.arcmed.2019.12.004. Epub 2020 Feb 18. Arch Med Res. 2020. PMID: 32086107
BACKGROUND AND AIMS: P-Coumaric acid (PCA) is one the compound that has free radical scavenging effects. ...METHODS: Thirty two Wistar rats were divided into control, PCA, DOX (15 mg/kg, i.p.) and DOX plus PCA (100 mg/kg, orally) groups. DOX-induced nephrotoxicity w …
BACKGROUND AND AIMS: P-Coumaric acid (PCA) is one the compound that has free radical scavenging effects. ...METHODS: Thirty two Wista …
Impact of resveratrol supplementation on clinical parameters and inflammatory markers in patients with chronic periodontitis: a randomized clinical trail.
Nikniaz S, Vaziri F, Mansouri R. Nikniaz S, et al. BMC Oral Health. 2023 Mar 27;23(1):177. doi: 10.1186/s12903-023-02877-4. BMC Oral Health. 2023. PMID: 36973728 Free PMC article. Clinical Trial.
RESULTS: The results showed that in both the case and control groups, after four weeks of using resveratrol, only plaque index (PI) was significantly different compared to the control group (P = 0.0001). However, there were no significant differences in the mean pocket dep …
RESULTS: The results showed that in both the case and control groups, after four weeks of using resveratrol, only plaque index (PI) was sign …
Human placental mesenchymal stromal cell-derived small extracellular vesicles as a treatment for severe COVID-19: A double-blind randomized controlled clinical trial.
Zamanian MH, Norooznezhad AH, Hosseinkhani Z, Hassaninia D, Mansouri F, Vaziri S, Payandeh M, Heydarpour F, Kiani S, Shirvani M, Rajati M, Bakhtiari M, Esmaili F, Yarani R, Mansouri K. Zamanian MH, et al. J Extracell Vesicles. 2024 Jul;13(7):e12492. doi: 10.1002/jev2.12492. J Extracell Vesicles. 2024. PMID: 39051747 Free PMC article. Clinical Trial.
Besides admission SpO(2) levels, which were significantly lower in the intervention arm (p = 0.008), all the baseline demo-biographic and laboratory variables were similar between the groups. It was shown that hPMSC-sEVs could significantly (p = 0.015) decrease the …
Besides admission SpO(2) levels, which were significantly lower in the intervention arm (p = 0.008), all the baseline demo-biographic …
Delayed Diagnosis of Chronic Necrotizing Granulomatous Skin Lesions due to TAP2 Deficiency.
Darazam IA, Hakamifard A, Momenilandi M, Materna M, Gharehbagh FJ, Shahrooei M, Olyaei NA, Zerehpoosh FB, Fayand A, Hatami F, Lotfollahi L, Mansouri N, Casanova JL, Béziat V, Mansouri D. Darazam IA, et al. J Clin Immunol. 2023 Jan;43(1):217-228. doi: 10.1007/s10875-022-01374-7. Epub 2022 Oct 13. J Clin Immunol. 2023. PMID: 36227411
1,279 results